Coty Valuation

Is CO3A undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CO3A when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CO3A (€6.92) is trading above our estimate of fair value (€5.78)

Significantly Below Fair Value: CO3A is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CO3A?

Key metric: As CO3A is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CO3A. This is calculated by dividing CO3A's market cap by their current earnings.
What is CO3A's PE Ratio?
PE Ratio40.9x
EarningsUS$157.50m
Market CapUS$6.45b

Price to Earnings Ratio vs Peers

How does CO3A's PE Ratio compare to its peers?

The above table shows the PE ratio for CO3A vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average40.2x
BEI Beiersdorf
37.6x12.7%€27.8b
HEN3 Henkel KGaA
19.1x6.5%€31.7b
500459 Procter & Gamble Hygiene and Health Care
76.4x15.9%₹516.3b
2367 Giant Biogene Holding
27.9x23.4%HK$53.0b
CO3A Coty
40.9x23.3%€6.4b

Price-To-Earnings vs Peers: CO3A is expensive based on its Price-To-Earnings Ratio (40.9x) compared to the peer average (40.2x).


Price to Earnings Ratio vs Industry

How does CO3A's PE Ratio compare vs other companies in the European Personal Products Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
CO3A 40.9xIndustry Avg. 22.3xNo. of Companies5PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: CO3A is expensive based on its Price-To-Earnings Ratio (40.9x) compared to the European Personal Products industry average (22.3x).


Price to Earnings Ratio vs Fair Ratio

What is CO3A's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CO3A PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio40.9x
Fair PE Ratio28.1x

Price-To-Earnings vs Fair Ratio: CO3A is expensive based on its Price-To-Earnings Ratio (40.9x) compared to the estimated Fair Price-To-Earnings Ratio (28.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CO3A forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€6.92
€9.77
+41.2%
19.6%€14.20€6.63n/a20
Nov ’25€6.79
€10.70
+57.5%
15.9%€13.85€7.39n/a20
Oct ’25€8.28
€11.27
+36.1%
14.9%€15.27€8.98n/a20
Sep ’25€8.38
€11.32
+35.1%
13.7%€15.19€8.94n/a20
Aug ’25€8.90
€11.88
+33.5%
11.9%€15.29€10.19n/a20
Jul ’25€9.17
€12.29
+34.1%
12.2%€15.40€10.26n/a20
Jun ’25€9.58
€12.20
+27.5%
11.3%€15.18€10.12n/a20
May ’25€10.73
€12.48
+16.3%
11.6%€16.35€10.28n/a21
Apr ’25€11.03
€12.50
+13.3%
12.2%€16.12€10.13n/a20
Mar ’25€11.61
€12.51
+7.8%
12.7%€16.19€9.71n/a20
Feb ’25€11.20
€12.17
+8.6%
11.9%€15.73€9.72n/a20
Jan ’25€11.15
€11.70
+4.9%
13.6%€15.59€9.17n/a20
Dec ’24€10.32
€11.52
+11.6%
13.6%€15.48€9.10n/a20
Nov ’24€8.67
€11.98
+38.2%
12.2%€14.07€9.38€6.7918
Oct ’24€10.32
€12.59
+22.1%
10.5%€15.01€10.32€8.2816
Sep ’24€10.69
€12.12
+13.4%
9.7%€13.81€10.13€8.3816
Aug ’24€10.59
€12.37
+16.8%
10.0%€15.50€10.49€8.9015
Jul ’24€11.23
€12.13
+8.0%
10.8%€14.60€10.49€9.1715
Jun ’24€10.21
€12.05
+18.0%
11.1%€14.57€10.47€9.5815
May ’24€10.71
€11.50
+7.3%
14.9%€14.58€7.52€10.7315
Apr ’24€11.03
€11.02
-0.1%
16.6%€13.84€7.61€11.0315
Mar ’24€10.57
€11.21
+6.1%
15.9%€14.15€7.78€11.6115
Feb ’24€9.27
€9.98
+7.7%
20.1%€13.80€6.44€11.2014
Jan ’24€7.82
€9.81
+25.4%
24.3%€14.33€6.69€11.1515
Dec ’23€7.42
€10.19
+37.3%
24.4%€14.98€6.99€10.3215
Nov ’23€6.89
€10.47
+52.0%
22.0%€15.19€7.09€8.6715

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies